Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Consumer Health New Products Roundup

This article was originally published in The Tan Sheet

Executive Summary

Daily iodine supplementation for premenstrual discomfort; immune system support from Hyperbiotics; Emerald Resources hammers natural in testosterone booster; Cetaphil line reaches babies; SuperNutrition gets HeartSmart; and Iovate Nature’s Food at GNC in U.S.

You may also be interested in...



Breast Discomfort Supplement Claims Were Poor Fit With Study Findings

BioPharmX can support claims its Violet Iodine breast discomfort supplement is designed for women with fibrocystic breast condition, as supported by study data, but must modify claims not specific to the conditions of the women in the study, including those with premenstrual breast discomfort.

Biogen Sees Improving Momentum In Slow Leqembi Launch

Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.

Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease

Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS107352

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel